Study on immune overreaction in heart infections pulled before start
NCT ID NCT06871215
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to look at how the immune system might contribute to heart valve damage in people with infective endocarditis, a serious bacterial infection of the heart. Researchers planned to analyze blood and heart valve tissue from patients to see if immune cells mistakenly attack the heart. However, the study was withdrawn before enrolling any participants, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFECTIVE ENDOCARDITIS (IE) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Barts Health NHS Trust
London, United Kingdom
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Simple dental exam before heart surgery may prevent deadly infections
- Iron and vitamins may boost recovery in heart infection patients
- Heart infection surgery outcomes examined in new study
- Gut bug to heart threat: scientists investigate hidden path to deadly infection
- New device sucks out deadly heart infections without open surgery